Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

Rosen & Barkin's 5-Minute Emergency Medicine Consult (589 page)

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
4.51Mb size Format: txt, pdf, ePub
ads
MEDICATION
  • Alteplase: 100 mg (peds: N/A) IV over 2 hr
  • Enoxaparin: 1 mg/kg (peds: 0.75 mg/kg) SC q12h
  • Reteplase: 10 U (peds: N/A) IV bolus q30min × 2
  • Streptokinase: 250,000 U (peds: 3,500–4,000 U/kg) IV bolus over 30 min, then 100,000 U (peds: 1,000–1,500 U/kg) IV maintenance over 24 hr
  • Unfractionated heparin:
    • Bolus: 80 U/kg (peds: 75 U/kg) IV over 10 min
    • Maintenance: 18 U/kg (peds: 20 U/kg) IV drip
    • Do not use TBW to calculate dose in obese patients.
  • Warfarin: 5 mg (peds: 0.05–0.34 mg/kg/d) PO per day, adjust for INR goal 2–3
  • Rivaroxaban: 15 mg BID × 3wks then 20mg QD
FOLLOW-UP
DISPOSITION
Admission Criteria
  • Admit all patients with PE for continued anticoagulation and observation.
  • Clinically stable patients with a high suspicion for PE, no contraindication to anticoagulation, and a lack of V/Q scanning or angiographic availability may be anticoagulated and studied when resources are available in the morning.
PEARLS AND PITFALLS
  • Clinical presentation is variable and nonspecific, making diagnosis difficult in many cases.
  • Patients with malignancy are at higher risk for Coumadin failure and recurrent PE even with therapeutic INR.
ADDITIONAL READING
  • Kline JA, Courtney DM, Kabrhel C, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria.
    J Thromb Haemost.
    2008;6(5):772–780.
  • Stein P, Fowler S, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism.
    N Eng J Med
    . 2006;354:2317–2327.
  • Stein PD, Woodward PK, Weg JG, et al. Diagnostic pathways in acute PE: Recommendations of the PIOPED II investigators.
    Am J Med
    . 2006;119:1048–1055.
  • van Belle A, Büller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
    JAMA.
    2006;295(2):172–179.
See Also (Topic, Algorithm, Electronic Media Element)
  • Chest Pain
  • Dyspnea
CODES
ICD9
  • 415.11 Iatrogenic pulmonary embolism and infarction
  • 415.19 Other pulmonary embolism and infarction
  • 673.20 Obstetrical blood-clot embolism, unspecified as to episode of care or not applicable
ICD10
  • I26.99 Other pulmonary embolism without acute cor pulmonale
  • O88.219 Thromboembolism in pregnancy, unspecified trimester
PURPURA
Richard E. Wolfe
•
Ashley L. Greiner
BASICS
DESCRIPTION
  • Skin lesionscaused by extravasation of blood into the skin or subcutaneous tissue
  • Can be caused by fragile capillaries, poor dermal support, and/or platelet dysfunction
  • The resultant lesions do not blanch completely with pressure (as seen when pressing down through a glass slide)
  • Nomenclature varies by the size of the lesions:
    • Petechiae (≤4 mm)
    • Purpuric lesions (5–10 mm)
    • Ecchymoses (>10 mm)
  • Color determined by depth and time of onset:
    • Red if superficial and recent onset
    • Purple if deep
    • Deep purple, brown, orange, or blue-green with later presentations
  • Nonpalpable purpura:
    • Simple hemorrhage or microvascular occlusion with ischemic hemorrhage
    • Generally due to a platelet disorder:
      • Diminished production
      • Altered distribution
      • Increased destruction
      • Abnormal function
  • Palpable purpura:
    • Generally due to vasculitis:
      • Autoimmune, small-vessel leukocytoclastic vasculitis
      • Hypersensitivity to various antigens
      • Formation of circulating immune complexes deposited in walls of postcapillary venules; activate complement that is chemotactic for polymorphonuclear leukocytes
      • Released enzymes damage vessel walls and cause leakage of blood
      • Vasculitic lesions may not be palpable in immunocompromised patients
ETIOLOGY
  • Nonpalpable purpura:
    • Viral:
      • Echovirus
      • Coxsackie
      • Measles
      • Parvovirus B19
    • Drugs:
      • Acetaminophen
      • Allopurinol
      • Anticoagulants
      • Aspirin
      • Digoxin
      • Furosemide
      • Gold salts
      • Lidocaine
      • Methyldopa
      • Nonsteroidal anti-inflammatory drugs
      • Penicillin G
      • Phenylbutazone
      • Quinidine
      • Quinine
      • Rifampin
      • Steroids
      • Sulfonamides
      • Thiazides
    • Nutritional deficiencies:
      • Vitamin K deficiency
      • Vitamin C deficiency (Scurvy)
    • Bone marrow disease
    • Hypersplenism
    • Idiopathic thrombocytopenic purpura (ITP)
    • Disseminated intravascular coagulation (DIC)
    • Thrombotic thrombocytopenic purpura
    • Liver or renal insufficiency
    • Thrombocytopenia (<50,000 plt/cc)
    • Thrombocytosis (>1,000,000 plt/cc)
    • Spiking elevations of intravascular pressure (childbirth, vomiting, paroxysmal coughing)
    • Hemophilia
    • Solar purpura (only on sun-exposed areas)
    • Post-transfusion
  • Palpable purpura:
    • Viral:
      • Echovirus type 9
      • Coxsackie
      • Hepatitis B
    • Streptococcal pharyngitis
    • Drugs:
      • Allopurinol
      • Anti-influenza vaccines
      • Cephalosporins
      • Gold
      • Heparin
      • Hydralazine
      • Iodides
      • Levamisole
      • Metoclopramide
      • Penicillin G
      • Phenylbutazone
      • Phenytoin
      • Quinidine
      • Quinine
      • Streptomycin
      • Sulfonamides
      • Thiazides
      • Ticlopidine
    • Malignancies
    • Autoimmune and connective tissue diseases
    • Gonococcus
    • Meningococcus
    • Pseudomonas
      (ecthyma gangrenosum)
    • Rocky Mountain spotted fever
    • In immunocompromised hosts:
      Candida
      ,
      Aspergillus
    • Occlusion due to organisms living in vessels (generally immunocompromised hosts): Mucormycosis, aspergillosis, and disseminated strongyloidiasis
    • Occlusion due to microvascular platelet plugs (heparin necrosis)
    • Cold-related gelling or agglutination (cryoglobulinemia)
    • Local or systemic coagulation abnormalities: Scarlet fever,
      Vibrio vulnificus
      bacteremia; “malignantchickenpox” and “black measles” (both rare in US); Coumadin necrosis
    • Embolization: Cholesterol, crystal, thrombus (atrial myxoma, septic endocarditis, multiple myeloma)
Pediatric Considerations
  • Henoch–Schönlein purpura
  • Hemolytic uremic syndrome
  • Kawasaki disease
  • Neonatal:
    • Extramedullary erythropoiesis in rubella and cytomegalovirus (blueberry muffin baby)
    • Purpura fulminans (protein C and S deficiency)
    • Maternal ITP
    • Wiskott–Aldrich syndrome
DIAGNOSIS
SIGNS AND SYMPTOMS
  • Palpable or nonpalpable, nonblanching lesions
  • Size:
    • Petechiae (≤4 mm)
    • Macular (5–10 mm)
    • Ecchymoses (>1 cm)
  • Shape:
    • Round lesions: Caused by leukocytoclastic emboli
    • Irregular (retiform) lesions: Caused by infectious emboli
    • Annular or erythema multiforme (target lesions)
  • Distribution:
    • Generalized: Consider DIC and meningococcemia
    • Dependent: Most common. Seen in the lower extremities (increased hydrostatic force)
    • Acral: Found in the extremities only
    • Oral/mucous membranes: Consider ITP
  • Hypotension
  • Altered mental status
  • Gingival hemorrhage
  • Epistaxis
  • Hematuria
  • Fever
  • Malaise
  • Arthralgias/hemarthroses
  • Myalgias
  • Purpura fulminans:
    • Large, irregular ecchymoses
    • Fever
    • Shock
    • DIC
  • Pseudomonas
    (ecthyma gangrenosum):
    • Begins as edematous, erythematous papules
    • Bullae formation in girdle region
  • Disseminated gonococcal infection:
    • Usually <10 lesions, purpuric papules, or vesicopustules on the extensor surface of hands, dorsal aspect of ankles and toes
    • Fever
    • Arthralgias
  • Meningococcemia:
    • Small areas of skin infarction cause retiform purpura
    • May involve head, palms, soles, mucous membranes, including conjunctivae
    • Fever
    • Headache
  • Rocky Mountain spotted fever:
    • After 4–7 days of generalized symptoms, erythematous macules on distal extremities including palms and soles, then petechial
    • Fever
    • Headache
  • Henoch–Schönlein purpura:
    • Appears on extensor aspects of lower extremities and buttocks
    • Fades in about 5 days
    • Fever
    • Arthralgias
    • Abdominal pain
    • Hematuria
  • Kawasaki disease:
    • Purpura is rare
    • Fever, plus 4 of the following: Polymorphous exanthem, peripheral extremity changes, bilateral conjunctivitis, changes of lips and mouth, unilateral cervical lymphadenopathy
  • Levamisole adulterated cocaine:
    • Retiform, necrotic purpura involving the ears/face but can occur anywhere
    • Neutropenia
    • Recurrent symptoms with continued abuse
BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
4.51Mb size Format: txt, pdf, ePub
ads

Other books

The China Doll by Deborah Nam-Krane
Family Reunion by Keyes, Mercedes
Beyond the Bounty by Tony Parsons
Revenant Eve by Sherwood Smith
Tempting Fate by Jane Green
Shadows of Golstar by Terrence Scott
The Fire Artist by Whitney, Daisy
The Cursed by Heather Graham